Alkem Laboratories Ltd
NSE:ALKEM
Relative Value
The Relative Value of one
ALKEM
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 5 669.5 INR,
Alkem Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ALKEM Competitors Multiples
Alkem Laboratories Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Alkem Laboratories Ltd
NSE:ALKEM
|
677.9B INR | 4.8 | 28.6 | 22.1 | 25.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
975.1B USD | 15.1 | 47.5 | 32 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.4B USD | 6.4 | 22.3 | 15.5 | 19 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
293B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.7B CHF | 5.7 | 23 | 14.2 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
240.5B GBP | 5.5 | 31.7 | 17.5 | 24.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.1B USD | 4.7 | 16.9 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.9B USD | 2.6 | 17.9 | 7.5 | 9.2 |